Charles William Rowe

USPTO Granted Patents = 9 (Patent Applications = 3)

CIPO Patents = 5 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 3.7

ph-index = 8

Forward Citations = 481(Granted Patents)

Location History:

Medford, MA (US) (2003 - 2014)
San Bruno, CA (US) (2018 - 2024)

Company Filing History:

4 out of 8,373

Massachusetts Institute of Technology

patents

2 out of 1,151

Vertex Pharmaceuticals, Inc.

patents

2 out of 923

Gilead Sciences, Inc.

Years Active: 2003-2024

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11944611 - Capsid inhibitors for the treatment of HIV (2024-04-02),

2. 10071985 - Therapeutic compounds (2018-09-11),

3. 8758658 - System and method for uniaxial compression of an article, such as a three dimensionally printed dosage form (2014-06-24),

4. 8076357 - Compositions of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (2011-12-13),

5. 7931914 - System and method for uniaxial compression of an article, such as a three-dimensionally printed dosage form (2011-04-26),

6. 7820201 - System for manufacturing controlled release dosage forms, such as zero-order release profile dosage form manufactured by three-dimensional printing (2010-10-26),

7. 7553855 - Compositions of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (2009-06-30),

8. 7300668 - System for manufacturing controlled release dosage forms, such as a zero-order release profile dosage form manufactured by three-dimensional printing (2007-11-27),

9. 6547994 - Rapid prototyping and manufacturing process (2003-04-15),

Title: An Overview of Inventor Charles William Rowe

Introduction

Charles William Rowe, based in Medford, MA, is an accomplished inventor with a remarkable portfolio of nine patents. His innovations primarily focus on therapeutic compounds aimed at combating viral infections, particularly those related to HIV. This article explores his latest patents, career highlights, and collaborations with other prominent professionals.

Latest Patents

One of Rowe's latest patents involves capsid inhibitors designed for the treatment of HIV. This patent describes compounds of Formula (Ia) and (Ib) or their pharmaceutically acceptable salts, which are particularly useful in treating heavily treatment-experienced patients with multidrug-resistant HIV infections. Additionally, he has developed other therapeutic compounds, as indicated in his patent disclosures for compounds of formula (Ia), (Ib), (IIa), and (IIb), which are effective in treating Retroviridae viral infections, including those caused by the HIV virus.

Career Highlights

Throughout his career, Rowe has made significant contributions to the field of virology and pharmacology. He has worked with prestigious institutions such as the Massachusetts Institute of Technology (MIT) and Vertex Pharmaceuticals, Inc., where his research and innovations have advanced the understanding of viral infections and their treatments.

Collaborations

Charles William Rowe has collaborated with notable professionals, including Wendy E. Pryce Lewis and Michael John Cima. These collaborations have enhanced his work, bringing together diverse expertise to tackle complex challenges in the realm of viral therapeutics.

Conclusion

Charles William Rowe stands out as a leading inventor in the field of therapeutic compounds for viral infections. With nine patents to his name, his contributions play a vital role in the ongoing battle against HIV and other viral threats. His work at esteemed institutions and collaboration with other experts further exemplify his commitment to innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.